Please wait a minute...
Clinical and Experimental Obstetrics & Gynecology  2020, Vol. 47 Issue (6): 887-894    DOI: 10.31083/j.ceog.2020.06.5517
Original Research Previous articles | Next articles
Vaginal assisted laparoscopic sacrocervicopexy with anterior colpotomy (VALSAC): technique and mean 20 months outcomes
O. Sevket1, T. Takmaz1, *(), A.C. Sevket2, A. Toprak3, P. Ozcan1
1Department of Obstetrics and Gynecology, Bezmialem University Faculty of Medicine, Istanbul, Turkey
2Department of Obstetrics and Gynecology, Private Okmeydanı Hospital, Istanbul, Turkey
3Department of Statistics, Bezmialem University Faculty of Medicine, Istanbul, Turkey
Download:  PDF(2810KB)  ( 146 ) Full text   ( 7 )
Export:  BibTeX | EndNote (RIS)      
Abstract  
The main purpose of our study is to evaluate the efficacy and safety of vaginal assisted laparoscopic sacrocervicopexy with anterior colpotomy (VALSAC) for apical pelvic organ prolapse. We retrospectively reviewed the results of twenty-three women with stage III and IV prolapse treated with VALSAC between April 2017 and June 2019. With a mean follow-up of 20 months, apical pelvic organ prolapse was cured in 95.7 % of patients. There was no complication in terms of mesh exposure, persistent pain, hematoma, infection. The mean pre- and post-operative POP-Q scores were, for the Aa point, 1.61 ± 1.82 cm and -1.96 ± 0.87 cm (p < 0.01), for the C point, 2.87 ± 1.6 cm and -5.26 ± 1.86 cm (p < 0.01) for the Ap point, -1.43 ± 0.89 cm and -2.09 ± 0.59 cm (p < 0.01). VALSAC is a promising minimally invasive technique for pelvic floor reconstruction that appears to provide good outcomes. Content: The main purpose of our study is to evaluate the efficacy and safety of vaginal assisted laparoscopic sacrocervicopexy with anterior colpotomy (VALSAC) for apical pelvic organ prolapse.
Key words:  Anterior colpotomy      Pelvic organ prolapse      Sacrocervicopexy      Supracervical hysterectomy      Y-mesh     
Submitted:  08 February 2020      Accepted:  25 May 2020      Published:  15 December 2020     
*Corresponding Author(s):  TAHA TAKMAZ     E-mail:  thtkmz@hotmail.com

Cite this article: 

O. Sevket, T. Takmaz, A.C. Sevket, A. Toprak, P. Ozcan. Vaginal assisted laparoscopic sacrocervicopexy with anterior colpotomy (VALSAC): technique and mean 20 months outcomes. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(6): 887-894.

URL: 

https://ceog.imrpress.com/EN/10.31083/j.ceog.2020.06.5517     OR     https://ceog.imrpress.com/EN/Y2020/V47/I6/887

[1] Eren Akbaba, Burak Sezgin, Ahmet Akın Sivaslıoğlu. Anatomical and clinical outcomes of vaginally assisted laparoscopiclateral suspension in comparison with laparoscopic lateral suspension[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(4): 935-941.
[2] Han Bich Choi, Moon Kyoung Cho, Chul Hong Kim. Comparison of vaginal hysterectomy with McCall culdoplasty and transvaginal mesh surgery in the management of female pelvic organ prolapse[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(2): 389-394.
[3] Shaadaiti Wufuer, XiaoHui Wan, Buhaiqiemu Kadeer, Adilai Maimaitimin, Gulina Ababaikeli. Expression of pelvic organ prolapse-related protein fibulin-5, TGFβ, and Smad2/3 in Uyghur women of Xinjiang[J]. Clinical and Experimental Obstetrics & Gynecology, 2021, 48(2): 416-422.
[4] G. Calongos, Y. Tsuji, Y. Ito, M. Handa, Y. Kubota, A. Ida. Short term outcomes of a new non-dissection minimally invasive surgery method for cystocele repair[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(3): 355-358.
[5] N. Haya, I. Feferkorn, F. Fares, N. Azzam, R. Auslender, Y. Abramov. Elastin genetic point mutation and the risk of pelvic organ prolapse[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(1): 75-78.
[6] H. H. Chill, R. H. Yahya, M. Olek, S. Herzberg, S. Lesser, D. Shveiky. Anatomical outcome and patient satisfaction after two-stitch utero-sacral ligament suspension[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(6): 906-909.
[7] A. Klimczak, G. Kilic, B.S. Unlu, Y.-L. Lin, Y.-F. Kuo, M. Borahay. Pelvic organ prolapse surgery after different hysterectomy methods: a population-based cohort study[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(3): 466-472.
[8] N. Danandeh Osgui, P. Bastani. Improvement of concomitant symptoms of pelvic organ prolapsed with applied pessary[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(1): 42-44.
[9] G. Sukgen. Laparoscopic hysterectomy with anterior four-arm mesh implant technique in the surgical treatment of a woman with pelvic organ prolapse and urinary incontinence: a case report and review of the literature[J]. Clinical and Experimental Obstetrics & Gynecology, 2019, 46(1): 161-163.
[10] G. Sukgen, A. Altunkol, D. Abat. Comparison between four- and six-arm pelvic organ polypropylene mesh implantation for the treatment of pelvic organ prolapse[J]. Clinical and Experimental Obstetrics & Gynecology, 2018, 45(3): 414-418.
[11] K. Kai, Y. Kai, M. Nishida, K. Nasu, S. Iwanaga, H. Narahara. Modified Gilliam-Doleris hysteropexy for juvenile uterovaginal prolapse[J]. Clinical and Experimental Obstetrics & Gynecology, 2018, 45(1): 109-111.
[12] F. Nobili, A. Lukic, I. Puccica, M. Vitali, M. Schimberni, F. Manzara, A. Frega, B. Mossa, M. Moscarini, D. Caserta. The relevance of fascial surgical repair in the management of pelvic organ prolapse (POP)[J]. Clinical and Experimental Obstetrics & Gynecology, 2017, 44(5): 744-748.
[13] J.G.L. Riviere, T.R.H. Pruiksma, N. Jacquemyn, Y. Jacquemyn. Sexual function in women after vaginal surgery with synthetic mesh material[J]. Clinical and Experimental Obstetrics & Gynecology, 2014, 41(3): 258-260.
[14] T.O. Adedipe, S.J. Vine. Immediate and perioperative outcomes of polypropylene mesh in pelvic floor repair in a predominantly obese population[J]. Clinical and Experimental Obstetrics & Gynecology, 2010, 37(4): 266-268.
[15] G. Koutsougeras, P. Nicolaou, D. Karamanidis, G. Chimonis, A. Byros, E. Hatzopoulos. Effectiveness of transvaginal colporrhaphy with porcinacellular collagen matrix in the treatment of moderate to severe cystoceles[J]. Clinical and Experimental Obstetrics & Gynecology, 2009, 36(3): 179-181.
No Suggested Reading articles found!